Megapregablin Capsule 150 mg (Pregabalin)

Adult dose

This medication should be taken orally in two divided doses regardless of food. 1. Neuropathic Pain 1) Peripheral Neuropathic Pain: The starting dose is 150 mg per day, and it can be increased to 300 mg per day after 3 to 7 days. If necessary, it may be further increased to a maximum of 600 mg per day at 7-day intervals. 2) Central Neuropathic Pain: Starting dose 150 mg per day, increase to 300 mg per day after one week.

Child dose

Safety and efficacy data are insufficient for children under 12 years of age and adolescents aged 12-17 years, so administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so if any mood changes or abnormal behavior signs occur during treatment, it should be reported to a healthcare professional immediately. Patients with allergies to the ingredients in this medication or those who have issues digesting lactose should not take this drug. Diabetic patients should be cautious as weight gain may require adjustments to diabetes medication doses. If symptoms of angioedema occur, the use of this medication should be discontinued immediately and consultation with a healthcare professional should be sought. Elderly patients are at higher risk of falling or injury due to dizziness or drowsiness caused by this medication. Vision changes, such as blurred vision, may occur, and if such symptoms appear, consultation with a healthcare professional is recommended. Abruptly discontinuing the medication may lead to withdrawal symptoms like insomnia, headaches, and anxiety, so it should be tapered off gradually following a healthcare professional's guidance. There is a risk of drug abuse or dependency, so patients with a history of substance abuse should be particularly cautious. Patients with severe cardiovascular disease or impaired kidney function may require dose adjustments, and caution is advised when taken with opioid analgesics due to an increased risk of central nervous system depression. Pregnant women should avoid this medication during the early stages of pregnancy due to the risk of fetal malformations, and women of childbearing age should use effective contraception. This medication may cause dizziness and drowsiness, so caution is necessary when driving or operating dangerous machinery. Severe skin reactions may occur rarely; if abnormal skin symptoms develop, the medication should be stopped immediately and the healthcare professional informed. In case of overdose, signs such as confusion, drowsiness, or seizures may occur, requiring immediate medical attention. Keep out of reach of children and avoid transferring to other containers for safety.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, peeling skin, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), profound drowsiness, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urinary retention

Mild side effects

• Dizziness
• drowsiness
• confusion
• loss of direction sense
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication may be sensitive to air and moisture, so it should be stored in a sealed container. It is advisable to keep the storage temperature between 15 to 30 degrees Celsius.

Appearance

A hard capsule with a white or light yellow powder inside that appears white.

Package unit

30 capsules per bottle, 60 capsules per bottle